Paul Matteis

Stock Analyst at Stifel

(0.83)
# 2176
Out of 5,331 analysts
138
Total ratings
34.92%
Success rate
0.01%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
300 345
259.2 33.1% 13 Mar 31, 2025
NMRA Neumora Therapeutics
Downgrades: Hold
6 2
0.79 153.16% 2 Mar 7, 2025
RYTM Rhythm Pharmaceutica...
Reinstates: Buy
78
64 21.88% 1 Mar 5, 2025
SION Sionna Therapeutics
Initiates Coverage On: Buy
32
13.63 134.78% 1 Mar 4, 2025
CMPS Compass Pathways
Initiates Coverage On: Buy
11
4.2 161.9% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 32
11.38 181.2% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
490 494
500.87 -1.37% 18 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 32
14.8 116.22% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 6
7.27 -17.47% 5 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.29 210.08% 4 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
2.44 309.84% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 60
17.05 251.91% 2 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25 36
31.82 13.14% 7 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 87
61.91 40.53% 8 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 66
11.86 456.49% 3 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
11.32 209.19% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 53
32.77 61.73% 5 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 21
14.88 41.13% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
4.11 605.6% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
141 144
109.71 31.26% 8 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
315 287
123.38 132.61% 6 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
4.63 331.97% 1 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.39 402.09% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24
1.58 1418.99% 2 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 295
n/a n/a 4 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 54
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
36 5
0.29 1624.14% 2 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 32
13.62 134.95% 1 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
2.72 782.35% 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
n/a n/a 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
1.08 2400% 1 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 23
n/a n/a 2 Dec 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 140
n/a n/a 7 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
8.69 61.1% 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3000 2280
n/a n/a 1 Oct 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
25 31
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 18
n/a n/a 2 Feb 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 64
8.1 690.12% 1 Feb 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 22
n/a n/a 2 Oct 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
340
21.63 1471.89% 1 Dec 21, 2016